Literature DB >> 22547580

Beyond Hox: the role of ParaHox genes in normal and malignant hematopoiesis.

Vijay P S Rawat1, R Keith Humphries, Christian Buske.   

Abstract

During the past decade it was recognized that homeobox gene families such as the clustered Hox genes play pivotal roles both in normal and malignant hematopoiesis. More recently, similar roles have also become apparent for members of the ParaHox gene cluster, evolutionarily closely related to the Hox gene cluster. This is in particular found for the caudal-type homeobox genes (Cdx) genes, known to act as upstream regulators of Hox genes. The CDX gene family member CDX2 belongs to the most frequent aberrantly expressed proto-oncogenes in human acute leukemias and is highly leukemogenic in experimental models. Correlative studies indicate that CDX2 functions as master regulator of perturbed HOX gene expression in human acute myeloid leukemia, locating this ParaHox gene at a central position for initiating and maintaining HOX gene dysregulation as a driving leukemogenic force. There are still few data about potential upstream regulators initiating aberrant CDX2 expression in human leukemias or about critical downstream targets of CDX2 in leukemic cells. Characterizing this network will hopefully open the way to therapeutic approaches that target deregulated ParaHox genes in human leukemia.

Entities:  

Mesh:

Year:  2012        PMID: 22547580      PMCID: PMC3448567          DOI: 10.1182/blood-2012-02-385898

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  83 in total

1.  Evidence for positive and negative regulation of the mouse Cdx2 gene.

Authors:  Wayne C H Wang; Cooduvalli S Shashikant
Journal:  J Exp Zool B Mol Dev Evol       Date:  2007-05-15       Impact factor: 2.656

2.  The ParaHox gene cluster is an evolutionary sister of the Hox gene cluster.

Authors:  N M Brooke; J Garcia-Fernàndez; P W Holland
Journal:  Nature       Date:  1998-04-30       Impact factor: 49.962

3.  Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny.

Authors:  Nicolas Pineault; Cheryl D Helgason; H Jeffrey Lawrence; R Keith Humphries
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

4.  Colonic hamartoma development by anomalous duplication in Cdx2 knockout mice.

Authors:  Y Tamai; R Nakajima; T Ishikawa; K Takaku; M F Seldin; M M Taketo
Journal:  Cancer Res       Date:  1999-06-15       Impact factor: 12.701

5.  Embryonic stem cell-derived hematopoietic stem cells.

Authors:  Yuan Wang; Frank Yates; Olaia Naveiras; Patricia Ernst; George Q Daley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-15       Impact factor: 11.205

Review 6.  Genomic approaches to the pathogenesis and treatment of acute lymphoblastic leukemias.

Authors:  Scott A Armstrong; James J-D Hsieh; Stanley J Korsmeyer
Journal:  Curr Opin Hematol       Date:  2002-07       Impact factor: 3.284

7.  Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival.

Authors:  Hanno Hock; Eliza Meade; Sarah Medeiros; Jeffrey W Schindler; Peter J M Valk; Yuko Fujiwara; Stuart H Orkin
Journal:  Genes Dev       Date:  2004-09-15       Impact factor: 11.361

8.  An FGF4-FRS2alpha-Cdx2 axis in trophoblast stem cells induces Bmp4 to regulate proper growth of early mouse embryos.

Authors:  Michiko Murohashi; Takahisa Nakamura; Satoshi Tanaka; Taeko Ichise; Nobuaki Yoshida; Tadashi Yamamoto; Masabumi Shibuya; Joseph Schlessinger; Noriko Gotoh
Journal:  Stem Cells       Date:  2010-01       Impact factor: 6.277

9.  Cdx1, a dispensable homeobox gene for gut development with limited effect in intestinal cancer.

Authors:  C Bonhomme; A Calon; E Martin; S Robine; A Neuville; M Kedinger; C Domon-Dell; I Duluc; J-N Freund
Journal:  Oncogene       Date:  2008-03-31       Impact factor: 9.867

10.  PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum.

Authors:  M F Offield; T L Jetton; P A Labosky; M Ray; R W Stein; M A Magnuson; B L Hogan; C V Wright
Journal:  Development       Date:  1996-03       Impact factor: 6.868

View more
  17 in total

1.  Insulin-like growth factor 1 is a direct HOXA9 target important for hematopoietic transformation.

Authors:  J Steger; E Füller; M-P Garcia-Cuellar; K Hetzner; R K Slany
Journal:  Leukemia       Date:  2014-09-25       Impact factor: 11.528

2.  HOXB9 acts as a negative regulator of activated human T cells in response to amino acid deficiency.

Authors:  Keitaro Hayashi; Motoshi Ouchi; Hitoshi Endou; Naohiko Anzai
Journal:  Immunol Cell Biol       Date:  2016-03-01       Impact factor: 5.126

3.  The ParaHox gene Cdx4 induces acute erythroid leukemia in mice.

Authors:  Silvia Thoene; Tamoghna Mandal; Naidu M Vegi; Leticia Quintanilla-Martinez; Reinhild Rösler; Sebastian Wiese; Klaus H Metzeler; Tobias Herold; Torsten Haferlach; Konstanze Döhner; Hartmut Döhner; Luisa Schwarzmüller; Ursula Klingmüller; Christian Buske; Vijay P S Rawat; Michaela Feuring-Buske
Journal:  Blood Adv       Date:  2019-11-26

Review 4.  Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets.

Authors:  C T Collins; J L Hess
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

5.  Structure-Function Analysis of the Drosophila melanogaster Caudal Transcription Factor Provides Insights into Core Promoter-preferential Activation.

Authors:  Hila Shir-Shapira; Julia Sharabany; Matan Filderman; Diana Ideses; Avital Ovadia-Shochat; Mattias Mannervik; Tamar Juven-Gershon
Journal:  J Biol Chem       Date:  2015-05-26       Impact factor: 5.157

Review 6.  Long noncoding RNAs: emerging regulators of normal and malignant hematopoiesis.

Authors:  Yi Qiu; Mingjiang Xu; Suming Huang
Journal:  Blood       Date:  2021-12-09       Impact factor: 22.113

7.  CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.

Authors:  Katrin Faber; Lars Bullinger; Christine Ragu; Angela Garding; Daniel Mertens; Christina Miller; Daniela Martin; Daniel Walcher; Konstanze Döhner; Hartmut Döhner; Rainer Claus; Christoph Plass; Stephen M Sykes; Steven W Lane; Claudia Scholl; Stefan Fröhling
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

8.  The leukemogenicity of Hoxa9 depends on alternative splicing.

Authors:  C R Stadler; N Vegi; M A Mulaw; K E Edmaier; V P S Rawat; A Dolnik; L Bullinger; B Heilmeier; L Quintanilla-Fend; K Spiekermann; W Hiddemann; K Döhner; H Döhner; M Feuring-Buske; C Buske
Journal:  Leukemia       Date:  2014-02-18       Impact factor: 11.528

9.  CTCF boundary remodels chromatin domain and drives aberrant HOX gene transcription in acute myeloid leukemia.

Authors:  Huacheng Luo; Fei Wang; Jie Zha; Haoli Li; Bowen Yan; Qinghua Du; Fengchun Yang; Amin Sobh; Christopher Vulpe; Leylah Drusbosky; Christopher Cogle; Iouri Chepelev; Bing Xu; Stephen D Nimer; Jonathan Licht; Yi Qiu; Baoan Chen; Mingjiang Xu; Suming Huang
Journal:  Blood       Date:  2018-05-14       Impact factor: 22.113

10.  Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic Erosion.

Authors:  Ayala Tovy; Jaime M Reyes; Michael C Gundry; Lorenzo Brunetti; Henry Lee-Six; Mia Petljak; Hyun Jung Park; Anna G Guzman; Carina Rosas; Aaron R Jeffries; Emma Baple; Jonathan Mill; Andrew H Crosby; Valerie Sency; Baozhong Xin; Heather E Machado; Danielle Castillo; Jeffrey N Weitzel; Wei Li; Michael R Stratton; Peter J Campbell; Heng Wang; Mathijs A Sanders; Margaret A Goodell
Journal:  Cell Stem Cell       Date:  2020-07-15       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.